TOG Review (RCOG Journal)
MRCOG Part 2
Maternal Medicine
Tuberculosis in pregnancy
Key Statistics
- 9.9M/1.3M — Global TB incidence/deaths 1990–2020
- 6.9/100,000 — UK TB rate, 2020 (4700 cases)
- 0.06–11% — Active TB prevalence in pregnancy (HIV−/HIV+)
Don't-miss facts
-
Untreated TB carries greater maternal/fetal risk than treatment – always treat; treatment doses/duration are not altered for pregnancy or gestation (NICE)
-
Standard regimen: 2 months HRZE + 4 months HR (6 months); CNS TB: 2HRZE + 10HR (12 months) + corticosteroids 4–8 weeks. Pyridoxine 10mg/day throughout with isoniazid
-
Streptomycin is the one first-line drug to avoid – 15% risk of irreversible neonatal deafness
-
Latent TB: treat from the first trimester (do not delay to 2nd trimester) – isoniazid 6 months, or isoniazid + rifampicin 3 months, with pyridoxine
-
MRI preferred over CT for imaging in pregnancy (pelvic CT doubles baseline childhood cancer risk 1:2000→2:2000)
-
HIV ↑reactivation of latent TB 20-fold; WHO recommends isoniazid preventive therapy + ART in HIV-positive pregnant women without diagnosed LTBI
-
Perinatal TB mortality 22% treated vs 38% untreated; Cantwell criteria used for diagnosis; treat as adult (2HRZE/4HRE)
- pyridoxine
- Breastfeeding safe once mother has completed ≥2 weeks treatment; avoid if breast TB, MDR/XDR-TB, or HIV coinfection. BCG is a live vaccine – contraindicated in pregnancy
Diagnostic pathway snapshot
Screening: TST (Mantoux, 48–72h read) / IGRA / C-Tb Confirmatory: ZN microscopy, culture (L–J or liquid), PCR/LiPA
CT avoided in pregnancy – use MRI
Abbreviation Key
- TB — tuberculosis
- LAM — lipoarabinomannan
- WHO — World Health Organization
- CXR — chest X-ray
- HIV — human immunodeficiency virus
- MRI — magnetic resonance imaging
- LTBI — latent tuberculosis infection
- CT — computerised tomography
- PHE — Public Health England
- NICE — National Institute for Health and Care Excellence
- STOP — screening for TB in pregnancy (programme)
- HRZE — isoniazid, rifampicin, pyrazinamide, ethambutol
- TST — TB skin test
- SCAR — severe cutaneous adverse reaction
- PPD — purified protein derivative
- FDA/CDC — Food and Drug Administration / Centers for Disease Control and Prevention (USA)
- IGRA — interferon gamma release assay
- ART — antiretroviral treatment
- AFB — acid-fast bacilli
- SCID — severe combined immunodeficiency
- PCR — polymerase chain reaction
- BCG — Bacille Calmette–Guérin (vaccine)
- LiPA — line probe assay
Source: Raveendran A et al. Tuberculosis in pregnancy. The Obstetrician & Gynaecologist 2023;25:175–185. doi:10.1111/tog.12888
MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).